http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12029746

Outgoing Links

Predicate Object
contentType Evaluation Study|Journal Article|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, Non-P.H.S.
endingPage 1022
issn 1368-8375
issueIdentifier 11
pageRange 1017-1022
publicationName Oral Oncology
startingPage 1017
bibliographicCitation Monti Hughes A, Pozzi EC, Heber EM, Thorp S, Miller M, Itoiz ME, Aromando RF, Molinari AJ, Garabalino MA, Nigg DW, Trivillin VA, Schwint AE. Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval. Oral Oncol. 2011 Nov;47(11):1017–22. doi: 10.1016/j.oraloncology.2011.07.014. PMID: 21840244.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd9bcdbfe97774ebb57094b67c49b289
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61521be7eb39ac5590ec5308a7cd4204
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_665b9d6e84447cfdbad1b9e17df08a08
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d27fb517a87152ff19f52759f13a9651
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6f1daf4409603c0b1333a64b6baa499
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51200fa1e6a500bea61609a1b939d627
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68039cd0d8bcc0c4524a7213e341f4df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bb32aca98c8438f6652bc1afc8c0156
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6e435d4a65e41d026cb46cd4d217cfb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd2dd138fa1894af4e3171a764a41aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c46522c6939c240d4912960cdafe254f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62a9eea4be7ef3b32052073c4a10eda1
date 201111
identifier https://pubmed.ncbi.nlm.nih.gov/21840244
https://doi.org/10.1016/j.oraloncology.2011.07.014
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20631
https://portal.issn.org/resource/ISSN/1368-8375
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Boron Neutron Capture Therapy (BNCT) in an oral precancer model: Therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval
discusses http://id.nlm.nih.gov/mesh/M0570383
http://id.nlm.nih.gov/mesh/M0016544
http://id.nlm.nih.gov/mesh/M0006644
http://id.nlm.nih.gov/mesh/M0104412
http://id.nlm.nih.gov/mesh/M0002832
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D011230Q000532
http://id.nlm.nih.gov/mesh/D009062Q000532
http://id.nlm.nih.gov/mesh/D001896Q000008
http://id.nlm.nih.gov/mesh/D016754Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D004247Q000096
http://id.nlm.nih.gov/mesh/D004195
http://id.nlm.nih.gov/mesh/D002610
http://id.nlm.nih.gov/mesh/D016754Q000009
http://id.nlm.nih.gov/mesh/D011833
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D010649Q000031
http://id.nlm.nih.gov/mesh/D052016Q000209
http://id.nlm.nih.gov/mesh/D006224
http://id.nlm.nih.gov/mesh/D010649Q000008
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6623
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8958
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150315
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7157
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53503

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128694259

Total number of triples: 61.